The Business Research Company published its Antisense & RNAi Therapeutics Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Antisense & RNAi Therapeutics market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers
the Antisense & RNAi Therapeutics market’s segments-
1) By Technology:
RNA Interference, Antisense RNA
2) By Route of
Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal
Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery
Methods
3) By Indication:
Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological
Disorders, Infectious Diseases, Other.
View Complete Report:
Antisense & RNAi Therapeutics Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The global antisense &RNAi therapeutics
market is expected to decline from $1.14 billion in 2019 to $1.11 billion in
2020 at a compound annual growth rate (CAGR) of -2.89%. The decline is mainly
due to the COVID-19 outbreak that has led to restrictive containment measures
involving social distancing, remote working, and the closure of industries and
other commercial activities resulting in operational challenges. The entire
supply chain has been disrupted, impacting the market negatively. The market is
then expected to recover and reach $1.44 billion in 2023 at a CAGR of 9.23%.
Major companies operating in the antisense
& RNAi therapeutics market are undertaking strategic initiatives such as
collaborations and partnerships for product innovation to sustain in the
increasingly competitive market, companies are developing innovative products
as well as sharing skills and expertise with other companies. While companies
have long collaborated with each other as well as with academic and research
institutions in this market by way of partnerships, and in or out-licensing
deals. This trend has been increasing over recent years.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Antisense & RNAi Therapeutics Market Characteristics
4. Antisense & RNAi Therapeutics Market Product Analysis
5. Antisense & RNAi Therapeutics Market Supply Chain
……
26. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics
Market
27. Antisense
& RNAi Therapeutics Market Trends And Strategies
28. Antisense
& RNAi Therapeutics Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $
Billion
Table 2: Global
Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global
Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic
and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 4: Global
Antisense & RNAi Therapeutics Market, Segmentation By Route of
Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $
Billion
Table 5: Global
Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic
and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
……..
Table 46: Alnylam Pharmaceuticals Financial Performance
Table 47: Benitec
Biopharma Ltd. Financial Performance
Table 48: Gene
Signal Financial Performance
Table 49:
GlaxoSmithKline Plc Financial Performance
Table 50: Ionis
Pharmaceuticals Financial Performance
About The Business Research Company:
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
15 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment